BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27314095)

  • 1. Membrane-proximal binding of STAT3 revealed by cancer-associated receptor variants.
    Ulaganathan VK; Ullrich A
    Mol Cell Oncol; 2016 May; 3(3):e1145176. PubMed ID: 27314095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline variant FGFR4  p.G388R exposes a membrane-proximal STAT3 binding site.
    Ulaganathan VK; Sperl B; Rapp UR; Ullrich A
    Nature; 2015 Dec; 528(7583):570-4. PubMed ID: 26675719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion.
    Kogan D; Grabner A; Yanucil C; Faul C; Ulaganathan VK
    J Clin Invest; 2018 May; 128(5):1867-1872. PubMed ID: 29438108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.
    Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y
    Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.
    Marmé F; Werft W; Benner A; Burwinkel B; Sinn P; Sohn C; Lichter P; Hahn M; Schneeweiss A
    Ann Oncol; 2010 Aug; 21(8):1636-1642. PubMed ID: 20147743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
    Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
    J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal Corticomedullary Mixed Tumor Associated With the
    Kanzawa M; Fukuoka H; Yamamoto A; Suda K; Shigemura K; Hara S; Imagawa N; Tsukamoto R; Aoyama Y; Nakamura Y; Fujisawa M; Ogawa W; Takahashi Y; Itoh T
    J Endocr Soc; 2020 Sep; 4(9):bvaa101. PubMed ID: 32803097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducer and activator of transcription 3: a year in review.
    Forbes LR; Milner J; Haddad E
    Curr Opin Hematol; 2016 Jan; 23(1):23-7. PubMed ID: 26574998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
    Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
    Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of STAT3 in autophagy.
    You L; Wang Z; Li H; Shou J; Jing Z; Xie J; Sui X; Pan H; Han W
    Autophagy; 2015; 11(5):729-39. PubMed ID: 25951043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
    Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
    Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.
    Whittle SB; Reyes S; Du M; Gireud M; Zhang L; Woodfield SE; Ittmann M; Scheurer ME; Bean AJ; Zage PE
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):131-8. PubMed ID: 26840079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors.
    Ezzat S; Wang R; Pintilie M; Asa SL
    Oncotarget; 2017 Jan; 8(2):3481-3494. PubMed ID: 27966451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Cho SH; Hong CS; Kim HN; Shin MH; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ
    Cancer Res Treat; 2017 Jul; 49(3):766-777. PubMed ID: 27857023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
    Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
    Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ying and Yang of STAT3 in Human Disease.
    Vogel TP; Milner JD; Cooper MA
    J Clin Immunol; 2015 Oct; 35(7):615-23. PubMed ID: 26280891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers.
    Bahrenberg G; Behrmann I; Barthel A; Hekerman P; Heinrich PC; Joost HG; Becker W
    Mol Endocrinol; 2002 Apr; 16(4):859-72. PubMed ID: 11923481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T
    Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
    J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.